List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 393 studies with search of: "Hyperkinesis"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed An Open-Label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: Vyvanse (lisdexamfetamine dimesylate), NRP104
2 Completed Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: NRP104
3 Recruiting Adverse Effect of Prolonged Methylphenidate Treatment on Cardiac Functions
Conditions: Attention Deficit Disorder With Hyperactivity;   Attention Deficit Disorder;   Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention:
4 Not yet recruiting A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorder
Interventions: Drug: JNJ-31001074 3 mg/d;   Drug: OROS methylphenidate HCl 54 mg/d;   Drug: JNJ-31001074 10 mg/d;   Drug: Atomoxetine 80 mg/d;   Drug: Placebo;   Drug: JNJ-31001074 1 mg/d
5 Not yet recruiting A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorder
Intervention: Drug: JNJ-31001074
6 Not yet recruiting A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
7 Recruiting Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
8 Completed Single Photon Emission Computed Tomography (SPECT) to Study Paroxysmal Hyperkinetic Movement Disorders
Condition: Hyperkinesis
Intervention:
9 Recruiting Cerebellar Loops and Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Other: Imaging
10 Recruiting Nutrient Intake in Children With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
11 Recruiting Breathing Meditation With Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Behavioral: Breathing Meditation
12 Completed Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: clonidine;   Drug: methylphenidate;   Other: placebo
13 Recruiting Clinical and Neuropsychological Validity of Attention-Deficit Hyperactivity Disorder in Adulthood
Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
14 Completed Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation
Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
15 Enrolling by invitation Effects of Ritalin on Postural Stability of Hyper Active Children
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: Ritalin
16 Completed Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: high dose clonidine HCl sustained release;   Drug: low dose clonidine HCl sustained release;   Drug: placebo
17 Recruiting Screening for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adolescent and Adult High Risk Populations
Condition: Attention Deficit Disorder With Hyperactivity
Intervention:
18 Completed CONCERTA® (OROS® Methylphenidate Hydrochloride) for the Treatment of Attention Deficit Hyperactivity Disorder in Adults
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate
19 Completed Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Disorder With Hyperactivity;   Dental Caries;   Dental Occlusion, Traumatic
Intervention:
20 Completed An Effectiveness and Safety Study of CONCERTA® (Methylphenidate Hydrochloride) in the Treatment of Adolescents With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: methylphenidate hydrochloride

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services